Kirthiga Reddy - Dec 3, 2021 Form 4 Insider Report for Pear Therapeutics, Inc. (PEARQ)

Role
Director
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
Stock symbol
PEARQ
Transactions as of
Dec 3, 2021
Transactions value $
$0
Form type
4
Date filed
12/7/2021, 04:25 PM
Previous filing
Oct 22, 2021
Next filing
Dec 10, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEARQ Stock Option (Right to Buy) Award $0 +70.6K $0.00 70.6K Dec 3, 2021 Class A Common Stock 70.6K $9.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable for 33% shares on December 3, 2022, 33% of the shares on December 3, 2023 and 34% of the shares on December 3, 2024.